SlideShare a Scribd company logo
PARACETAMOL ( ACETAMINIOPHAN )
POISONING
8/27/2018 1
Paracetamol poison cases admitted to
Poison Treatment Center NYGH
Year Male Female Total
2015 22 70 92
2016 21 88 109
2017 13 78 91
2018
(Jan to Apr)
9 32 41
8/27/2018 2
Causes severe hepatocellular necrosis and
less commonly acute tubular necrosis.
Rapidly absorbed from the small intestine.
Peak serum concentrations occur
within 1–2 hours for standard tablet or capsule
formulations and
within 30 minutes for liquid preparations.
8/27/2018 3
85% Conjugation
NAPQI
Glutathione
Paracetamol Mechanism
N-acetyl-p-benzoquinonamine
Hepatotoxicity
8/27/2018 4
Adults and children > 6 years of age Children aged 0–6 years
Acute
single
ingestion
> 200 mg/kg or 10 g (whichever is
less) over a period of less than
8 hours
≥ 200 mg/kg over a period of
less than 8 hours
Repeated
supra-
therapeutic
ingestion
> 200 mg/kg or 10 g (whichever is
less) over a single 24-hour period
> 150 mg/kg or 6 g (whichever is
less) per 24-hour period for the
preceding 48 hours
> 100 mg/kg or 4 g/day (whichever
is less) in patients with predisposing
risk factors
≥ 200 mg/kg over a single 24-
hour period
≥ 150 mg/kg per 24-hour period
for the preceding 48 hours
≥ 100 mg/kg per 24-hour period
for the preceding 72 hours
Paracetamol dosing that may be associated with hepatic injury
8/27/2018 5
High risk persons ( lower margin of safety )
Those taking enzyme inducing drugs
( eg. anticonvulsants, rifampicin )
Chronic alcoholics
Malnourished patients,
Fasting state
HIV positive patients.
8/27/2018 6
The key factors to consider
The ingested dose and serum paracetamol
concentration (early)
Clinical and laboratory features suggesting liver
damage (late).
8/27/2018 7
The best surrogate marker indicating the
potential for injury is a timed serum
paracetamol level plotted on a nomogram.
The nomogram cannot be applied for
repeated or staggered doses, or if the time of
ingestion cannot be determined with
confidence by the treating clinician.
8/27/2018 8
The most important risk factor for liver
damage and death after acute paracetamol
ingestion is the extent of delay beyond 8 hours
until treatment with NAC commences.
8/27/2018 9
Clinical Features-
Early after acute overdose, there are usually no symptoms other
than nausea and vomiting.
Clinical evidence of end-organ toxicity often does not manifest until
24-48 hours after an acute ingestion
After 24-48 hours, ALT and AST begin to rise(hepatic necrosis)
Acute renal failure occurs occasionally.
Liver damage is maximal 3-4 days after ingestion
Despite a lack of significant symptoms, patients should be referred
to hospital.
8/27/2018 10
Time after ingestion
TEST 1-8 hr 8-24 hr > 24 hr
Paracetamol
level
At 4 hours or as
soon thereafter
as possible
On admission On admission
GOT/GPT On admission
AND at end of
NAC infusion
On admission
PT/ INR On admission
Urea/ Creat On admission
Glucose On admission
ABG On admission
Recommended investigations
8/27/2018 11
• Transaminase X Paracetamol product
<10,000
– At the time treatment starts and again
at 12 hours
– Lifethreatening toxicity is unlikely
8/27/2018 12
8/27/2018 13
8/27/2018 14
8/27/2018 15
Three-stage N-acetylcysteine infusion
Initial
infusion
150 mg/kg of NAC diluted in 200 mL of 5%
glucose and infused over 15 to 60 minutes
Second
infusion
Followed by a continuous infusion of
50 mg/kg of NAC in 500 mL of 5% glucose
over the next 4 hours
Third
infusion
followed by a continuous infusion of
100 mg/kg of NAC in 1000 mL of 5%
glucose over the next 16 hours
8/27/2018 16
Anaphylactoid reactions ( 10-50% of patients during
first two NAC infusion)
Rash, wheeze or mild hypotension
Severe life-threatening reactions are very rare, but may
occur in predisposed individuals, such as patients with
asthma.
Management
Supportive, with temporary halting or slowing of the
infusion, and administration of antihistamines.
The occurrence of an anaphylactoid reaction does not
preclude the use of NAC on another occasion if
indicated.8/27/2018 17
Oral NAC ( available as mucolytic agent )
140 mg/kg stat
followed by
70mg/kg 4 hourly for 17 doses
with anti-emetic to prevent vomiting.
8/27/2018 18
The 2006 Cochrane review of several case series concluded there was no clear
difference in efficacy (in terms of hepatoxicity and mortality rates) between
intravenous and oral routes.
Oral NAC has been used for 30 years in the USA with similar efficacy and safety
Oral and Intravenous Acetylcysteine for Treatment of
Acetaminophen Toxicity:
A Systematic Review and Meta-analysis
(Green JL et. al. West J Emerg Med. 2013 May; 14(3): 218–226)
5164 patients in 16 articles
The overall rate of hepatotoxicity for the oral and IV routes were
12.6% and 13.2%, respectively.
8/27/2018 19
Don’t underestimate paracetamol poisoning
Stated timing and dose are often unreliable
and this needs to be taken into
consideration.
NAC is a safe and effective antidote.
Time to NAC is crucial.
May be asymptomatic in first 24 hours
8/27/2018 20

More Related Content

What's hot

Aspirin poisoning
Aspirin poisoningAspirin poisoning
Aspirin poisoning
Ahmed Amer
 
Acetaminophen overdose
Acetaminophen overdoseAcetaminophen overdose
Acetaminophen overdose
Dr Harikrishna Harindran
 
Iron Poisoning
Iron PoisoningIron Poisoning
Iron Poisoning
Haris Gujjar
 
Ssri.ppt 2013
Ssri.ppt 2013Ssri.ppt 2013
Ssri.ppt 2013
HAMAD DHUHAYR
 
AntiEpileptic Drugs
AntiEpileptic DrugsAntiEpileptic Drugs
AntiEpileptic Drugs
Kaushik Mukhopadhyay
 
Anti Amoebic Drugs
Anti Amoebic DrugsAnti Amoebic Drugs
Anti Amoebic Drugs
Dr Renju Ravi
 
Antidepressants toxictiy
Antidepressants toxictiyAntidepressants toxictiy
Antidepressants toxictiy
Amira Badr
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
Suvarta Maru
 
PARACETAMOL PHARMACOLOGY
PARACETAMOL PHARMACOLOGYPARACETAMOL PHARMACOLOGY
PARACETAMOL PHARMACOLOGY
Koppala RVS Chaitanya
 
Levocetirizine
LevocetirizineLevocetirizine
Levocetirizine
bdweiss
 
Histamine and antihistamin
Histamine and antihistaminHistamine and antihistamin
Histamine and antihistamin
Rakshitha Venkatesh
 
Paracetamol toxicity
Paracetamol toxicityParacetamol toxicity
Paracetamol toxicity
precordialthump
 
Paracetamol overdose
Paracetamol overdoseParacetamol overdose
Paracetamol overdose
Keerati Sup
 
Case Study on Paracetamol toxicity
Case Study on Paracetamol toxicityCase Study on Paracetamol toxicity
Case Study on Paracetamol toxicity
Neeraj Ojha
 
Antianginal drug
Antianginal drugAntianginal drug
Antianginal drug
pankaj rana
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
Naser Tadvi
 
proton pump inhibitors PPT
proton pump inhibitors PPTproton pump inhibitors PPT
proton pump inhibitors PPT
pharmastuffblogspotcom
 
Antipyretics
AntipyreticsAntipyretics
Antipyretics
Shweta Chavan
 
Benzodiazepines toxicity
Benzodiazepines  toxicityBenzodiazepines  toxicity
Benzodiazepines toxicity
Amira Badr
 
Potassium channel openers
Potassium channel openers Potassium channel openers
Potassium channel openers
Naser Tadvi
 

What's hot (20)

Aspirin poisoning
Aspirin poisoningAspirin poisoning
Aspirin poisoning
 
Acetaminophen overdose
Acetaminophen overdoseAcetaminophen overdose
Acetaminophen overdose
 
Iron Poisoning
Iron PoisoningIron Poisoning
Iron Poisoning
 
Ssri.ppt 2013
Ssri.ppt 2013Ssri.ppt 2013
Ssri.ppt 2013
 
AntiEpileptic Drugs
AntiEpileptic DrugsAntiEpileptic Drugs
AntiEpileptic Drugs
 
Anti Amoebic Drugs
Anti Amoebic DrugsAnti Amoebic Drugs
Anti Amoebic Drugs
 
Antidepressants toxictiy
Antidepressants toxictiyAntidepressants toxictiy
Antidepressants toxictiy
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
 
PARACETAMOL PHARMACOLOGY
PARACETAMOL PHARMACOLOGYPARACETAMOL PHARMACOLOGY
PARACETAMOL PHARMACOLOGY
 
Levocetirizine
LevocetirizineLevocetirizine
Levocetirizine
 
Histamine and antihistamin
Histamine and antihistaminHistamine and antihistamin
Histamine and antihistamin
 
Paracetamol toxicity
Paracetamol toxicityParacetamol toxicity
Paracetamol toxicity
 
Paracetamol overdose
Paracetamol overdoseParacetamol overdose
Paracetamol overdose
 
Case Study on Paracetamol toxicity
Case Study on Paracetamol toxicityCase Study on Paracetamol toxicity
Case Study on Paracetamol toxicity
 
Antianginal drug
Antianginal drugAntianginal drug
Antianginal drug
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
proton pump inhibitors PPT
proton pump inhibitors PPTproton pump inhibitors PPT
proton pump inhibitors PPT
 
Antipyretics
AntipyreticsAntipyretics
Antipyretics
 
Benzodiazepines toxicity
Benzodiazepines  toxicityBenzodiazepines  toxicity
Benzodiazepines toxicity
 
Potassium channel openers
Potassium channel openers Potassium channel openers
Potassium channel openers
 

Similar to Paracetamol poisoning ml nyein

Prof dr myo lwin nyein
Prof dr myo lwin nyeinProf dr myo lwin nyein
Prof dr myo lwin nyein
EhealthMoHS
 
Management of paracetamol overdose in adults
Management of paracetamol overdose in adultsManagement of paracetamol overdose in adults
Management of paracetamol overdose in adults
Ghassan Al kefeiri
 
Sean Kelly on Paracetamol Toxicity
Sean Kelly on Paracetamol ToxicitySean Kelly on Paracetamol Toxicity
Sean Kelly on Paracetamol Toxicity
SMACC Conference
 
Case study on paracetamol poisoning(Acetaminophen toxicity)
Case study on paracetamol poisoning(Acetaminophen toxicity)Case study on paracetamol poisoning(Acetaminophen toxicity)
Case study on paracetamol poisoning(Acetaminophen toxicity)
Neeraj Ojha
 
Tylenol Toxicity
Tylenol ToxicityTylenol Toxicity
Tylenol Toxicity
Rodolfo Rodrigo Acosta
 
Paracetamol Toxicity
Paracetamol ToxicityParacetamol Toxicity
Paracetamol Toxicity
A A
 
PARACETAMOL POISIONING.pptx
PARACETAMOL POISIONING.pptxPARACETAMOL POISIONING.pptx
PARACETAMOL POISIONING.pptx
akash chauhan
 
PARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptxPARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptx
shanbasat
 
Paracetamol toxicity or Acetaminophen toxicity
Paracetamol toxicity  or Acetaminophen toxicityParacetamol toxicity  or Acetaminophen toxicity
Paracetamol toxicity or Acetaminophen toxicity
VHARI5
 
Activase product monograph
Activase product          monographActivase product          monograph
Activase product monograph
Girgis Attia
 
ACTIVASE PRODUCT MONOGRAPH
ACTIVASE PRODUCT          MONOGRAPHACTIVASE PRODUCT          MONOGRAPH
ACTIVASE PRODUCT MONOGRAPH
Girgis Attia
 
Prostate carcinoma- hormonal therapy 2
Prostate  carcinoma- hormonal therapy 2Prostate  carcinoma- hormonal therapy 2
Prostate carcinoma- hormonal therapy 2
GovtRoyapettahHospit
 
Acetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatricsAcetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatrics
Mohammed Alharthi
 
Gentamicin and the Yorkshire-Hartford Regimen
Gentamicin and the Yorkshire-Hartford RegimenGentamicin and the Yorkshire-Hartford Regimen
Gentamicin and the Yorkshire-Hartford Regimen
Kev Frost
 
Management of Acetaminophen Toxicity1.ppt
Management of Acetaminophen Toxicity1.pptManagement of Acetaminophen Toxicity1.ppt
Management of Acetaminophen Toxicity1.ppt
paulmarino21
 
paracetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdfparacetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdf
DrYaqoobBahar
 
paracetamol toxicity
paracetamol toxicityparacetamol toxicity
paracetamol toxicity
RakanAlotaibi14
 
Toxicology
ToxicologyToxicology
Toxicology
ashishnair22
 
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...
PVI, PeerView Institute for Medical Education
 
Newer anti platelet drugs
Newer anti platelet drugsNewer anti platelet drugs
Newer anti platelet drugs
Rishit Harbada
 

Similar to Paracetamol poisoning ml nyein (20)

Prof dr myo lwin nyein
Prof dr myo lwin nyeinProf dr myo lwin nyein
Prof dr myo lwin nyein
 
Management of paracetamol overdose in adults
Management of paracetamol overdose in adultsManagement of paracetamol overdose in adults
Management of paracetamol overdose in adults
 
Sean Kelly on Paracetamol Toxicity
Sean Kelly on Paracetamol ToxicitySean Kelly on Paracetamol Toxicity
Sean Kelly on Paracetamol Toxicity
 
Case study on paracetamol poisoning(Acetaminophen toxicity)
Case study on paracetamol poisoning(Acetaminophen toxicity)Case study on paracetamol poisoning(Acetaminophen toxicity)
Case study on paracetamol poisoning(Acetaminophen toxicity)
 
Tylenol Toxicity
Tylenol ToxicityTylenol Toxicity
Tylenol Toxicity
 
Paracetamol Toxicity
Paracetamol ToxicityParacetamol Toxicity
Paracetamol Toxicity
 
PARACETAMOL POISIONING.pptx
PARACETAMOL POISIONING.pptxPARACETAMOL POISIONING.pptx
PARACETAMOL POISIONING.pptx
 
PARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptxPARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptx
 
Paracetamol toxicity or Acetaminophen toxicity
Paracetamol toxicity  or Acetaminophen toxicityParacetamol toxicity  or Acetaminophen toxicity
Paracetamol toxicity or Acetaminophen toxicity
 
Activase product monograph
Activase product          monographActivase product          monograph
Activase product monograph
 
ACTIVASE PRODUCT MONOGRAPH
ACTIVASE PRODUCT          MONOGRAPHACTIVASE PRODUCT          MONOGRAPH
ACTIVASE PRODUCT MONOGRAPH
 
Prostate carcinoma- hormonal therapy 2
Prostate  carcinoma- hormonal therapy 2Prostate  carcinoma- hormonal therapy 2
Prostate carcinoma- hormonal therapy 2
 
Acetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatricsAcetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatrics
 
Gentamicin and the Yorkshire-Hartford Regimen
Gentamicin and the Yorkshire-Hartford RegimenGentamicin and the Yorkshire-Hartford Regimen
Gentamicin and the Yorkshire-Hartford Regimen
 
Management of Acetaminophen Toxicity1.ppt
Management of Acetaminophen Toxicity1.pptManagement of Acetaminophen Toxicity1.ppt
Management of Acetaminophen Toxicity1.ppt
 
paracetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdfparacetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdf
 
paracetamol toxicity
paracetamol toxicityparacetamol toxicity
paracetamol toxicity
 
Toxicology
ToxicologyToxicology
Toxicology
 
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringi...
 
Newer anti platelet drugs
Newer anti platelet drugsNewer anti platelet drugs
Newer anti platelet drugs
 

More from EhealthMoHS

Nccpe report 2017
Nccpe report 2017Nccpe report 2017
Nccpe report 2017
EhealthMoHS
 
Myanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation planMyanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation plan
EhealthMoHS
 
Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)
EhealthMoHS
 
Mva
MvaMva
Module 6 emergency response
Module 6 emergency responseModule 6 emergency response
Module 6 emergency response
EhealthMoHS
 
Module 5 shipping &amp; transportation of inf materials 21 1-2018
Module 5 shipping &amp; transportation of inf materials 21 1-2018Module 5 shipping &amp; transportation of inf materials 21 1-2018
Module 5 shipping &amp; transportation of inf materials 21 1-2018
EhealthMoHS
 
Module 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazardModule 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazard
EhealthMoHS
 
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
EhealthMoHS
 
Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)
EhealthMoHS
 
Medical store management for smo
Medical store management for smoMedical store management for smo
Medical store management for smo
EhealthMoHS
 
Measurement of disease frequency
Measurement of disease frequencyMeasurement of disease frequency
Measurement of disease frequency
EhealthMoHS
 
Measles verification case definitions
Measles verification case definitionsMeasles verification case definitions
Measles verification case definitions
EhealthMoHS
 
Measles lecture 7.11.17
Measles lecture 7.11.17Measles lecture 7.11.17
Measles lecture 7.11.17
EhealthMoHS
 
Measles dr. al
Measles dr. alMeasles dr. al
Measles dr. al
EhealthMoHS
 
Maintain polio free status
Maintain polio free statusMaintain polio free status
Maintain polio free status
EhealthMoHS
 
Lec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohsLec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohs
EhealthMoHS
 
Lec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohsLec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohs
EhealthMoHS
 
Lec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohsLec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohs
EhealthMoHS
 
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
Lec 12 management of rheumatic fever   rheumatic heart disease for mohsLec 12 management of rheumatic fever   rheumatic heart disease for mohs
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
EhealthMoHS
 
Lec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohsLec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohs
EhealthMoHS
 

More from EhealthMoHS (20)

Nccpe report 2017
Nccpe report 2017Nccpe report 2017
Nccpe report 2017
 
Myanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation planMyanmar fetp intermediate implementation plan
Myanmar fetp intermediate implementation plan
 
Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)Myanmar cdc (14 12-17)
Myanmar cdc (14 12-17)
 
Mva
MvaMva
Mva
 
Module 6 emergency response
Module 6 emergency responseModule 6 emergency response
Module 6 emergency response
 
Module 5 shipping &amp; transportation of inf materials 21 1-2018
Module 5 shipping &amp; transportation of inf materials 21 1-2018Module 5 shipping &amp; transportation of inf materials 21 1-2018
Module 5 shipping &amp; transportation of inf materials 21 1-2018
 
Module 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazardModule 4 primary contaiment and other hazard
Module 4 primary contaiment and other hazard
 
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
Module 3 biosafety principles &amp; microbiologycal risk group 21 1-18
 
Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)Meningococcal meningitis (dr.yla)
Meningococcal meningitis (dr.yla)
 
Medical store management for smo
Medical store management for smoMedical store management for smo
Medical store management for smo
 
Measurement of disease frequency
Measurement of disease frequencyMeasurement of disease frequency
Measurement of disease frequency
 
Measles verification case definitions
Measles verification case definitionsMeasles verification case definitions
Measles verification case definitions
 
Measles lecture 7.11.17
Measles lecture 7.11.17Measles lecture 7.11.17
Measles lecture 7.11.17
 
Measles dr. al
Measles dr. alMeasles dr. al
Measles dr. al
 
Maintain polio free status
Maintain polio free statusMaintain polio free status
Maintain polio free status
 
Lec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohsLec 16 management of high risk patients for mohs
Lec 16 management of high risk patients for mohs
 
Lec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohsLec 14 basic ecg interpretation for mohs
Lec 14 basic ecg interpretation for mohs
 
Lec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohsLec 13 demonstration of advancecd life support for mohs
Lec 13 demonstration of advancecd life support for mohs
 
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
Lec 12 management of rheumatic fever   rheumatic heart disease for mohsLec 12 management of rheumatic fever   rheumatic heart disease for mohs
Lec 12 management of rheumatic fever rheumatic heart disease for mohs
 
Lec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohsLec 11 perioperative assessment for diabetes for mohs
Lec 11 perioperative assessment for diabetes for mohs
 

Recently uploaded

English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
MatSouthwell1
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
Monopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in TripuraMonopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in Tripura
SKG Internationals
 
Sexual Disorders.gender identity disorderspptx
Sexual Disorders.gender identity  disorderspptxSexual Disorders.gender identity  disorderspptx
Sexual Disorders.gender identity disorderspptx
Pupayumnam1
 
一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理
40fortunate
 
Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...
Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...
Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...
Pristyn Care Reviews
 
muscluskeletal assessment...........pptx
muscluskeletal assessment...........pptxmuscluskeletal assessment...........pptx
muscluskeletal assessment...........pptx
RushikeshHange1
 
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdfData-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Jasper Colin
 
3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx
habtegirma
 
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
DrDevTaneja1
 
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
xkute
 
Fit to Fly PCR Covid Testing at our Clinic Near You
Fit to Fly PCR Covid Testing at our Clinic Near YouFit to Fly PCR Covid Testing at our Clinic Near You
Fit to Fly PCR Covid Testing at our Clinic Near You
NX Healthcare
 
Top 5 Benefits of Cancer Registry Services
Top 5 Benefits of Cancer Registry ServicesTop 5 Benefits of Cancer Registry Services
Top 5 Benefits of Cancer Registry Services
Cardiac Registry Support
 
The Ultimate Guide in Setting Up Market Research System in Health-Tech
The Ultimate Guide in Setting Up Market Research System in Health-TechThe Ultimate Guide in Setting Up Market Research System in Health-Tech
The Ultimate Guide in Setting Up Market Research System in Health-Tech
Gokul Rangarajan
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)
Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)
Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)
Aditi Jagtap Pune
 
nursing management of patient with Empyema ppt
nursing management of patient with Empyema pptnursing management of patient with Empyema ppt
nursing management of patient with Empyema ppt
blessyjannu21
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
marynayjun112024
 
India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...
India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...
India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...
Kumar Satyam
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 

Recently uploaded (20)

English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
Monopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in TripuraMonopoly PCD Pharma Franchise in Tripura
Monopoly PCD Pharma Franchise in Tripura
 
Sexual Disorders.gender identity disorderspptx
Sexual Disorders.gender identity  disorderspptxSexual Disorders.gender identity  disorderspptx
Sexual Disorders.gender identity disorderspptx
 
一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理一比一原版(USF毕业证)旧金山大学毕业证如何办理
一比一原版(USF毕业证)旧金山大学毕业证如何办理
 
Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...
Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...
Enhancing Hip and Knee Arthroplasty Precision with Preoperative CT and MRI Im...
 
muscluskeletal assessment...........pptx
muscluskeletal assessment...........pptxmuscluskeletal assessment...........pptx
muscluskeletal assessment...........pptx
 
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdfData-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
 
3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx
 
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
 
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
 
Fit to Fly PCR Covid Testing at our Clinic Near You
Fit to Fly PCR Covid Testing at our Clinic Near YouFit to Fly PCR Covid Testing at our Clinic Near You
Fit to Fly PCR Covid Testing at our Clinic Near You
 
Top 5 Benefits of Cancer Registry Services
Top 5 Benefits of Cancer Registry ServicesTop 5 Benefits of Cancer Registry Services
Top 5 Benefits of Cancer Registry Services
 
The Ultimate Guide in Setting Up Market Research System in Health-Tech
The Ultimate Guide in Setting Up Market Research System in Health-TechThe Ultimate Guide in Setting Up Market Research System in Health-Tech
The Ultimate Guide in Setting Up Market Research System in Health-Tech
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)
Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)
Daughter's of Dr Ranjit Jagtap (Poulami & Aditi)
 
nursing management of patient with Empyema ppt
nursing management of patient with Empyema pptnursing management of patient with Empyema ppt
nursing management of patient with Empyema ppt
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
 
India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...
India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...
India Medical Devices Market: Size, Share, and In-Depth Competitive Analysis ...
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 

Paracetamol poisoning ml nyein

  • 1. PARACETAMOL ( ACETAMINIOPHAN ) POISONING 8/27/2018 1
  • 2. Paracetamol poison cases admitted to Poison Treatment Center NYGH Year Male Female Total 2015 22 70 92 2016 21 88 109 2017 13 78 91 2018 (Jan to Apr) 9 32 41 8/27/2018 2
  • 3. Causes severe hepatocellular necrosis and less commonly acute tubular necrosis. Rapidly absorbed from the small intestine. Peak serum concentrations occur within 1–2 hours for standard tablet or capsule formulations and within 30 minutes for liquid preparations. 8/27/2018 3
  • 5. Adults and children > 6 years of age Children aged 0–6 years Acute single ingestion > 200 mg/kg or 10 g (whichever is less) over a period of less than 8 hours ≥ 200 mg/kg over a period of less than 8 hours Repeated supra- therapeutic ingestion > 200 mg/kg or 10 g (whichever is less) over a single 24-hour period > 150 mg/kg or 6 g (whichever is less) per 24-hour period for the preceding 48 hours > 100 mg/kg or 4 g/day (whichever is less) in patients with predisposing risk factors ≥ 200 mg/kg over a single 24- hour period ≥ 150 mg/kg per 24-hour period for the preceding 48 hours ≥ 100 mg/kg per 24-hour period for the preceding 72 hours Paracetamol dosing that may be associated with hepatic injury 8/27/2018 5
  • 6. High risk persons ( lower margin of safety ) Those taking enzyme inducing drugs ( eg. anticonvulsants, rifampicin ) Chronic alcoholics Malnourished patients, Fasting state HIV positive patients. 8/27/2018 6
  • 7. The key factors to consider The ingested dose and serum paracetamol concentration (early) Clinical and laboratory features suggesting liver damage (late). 8/27/2018 7
  • 8. The best surrogate marker indicating the potential for injury is a timed serum paracetamol level plotted on a nomogram. The nomogram cannot be applied for repeated or staggered doses, or if the time of ingestion cannot be determined with confidence by the treating clinician. 8/27/2018 8
  • 9. The most important risk factor for liver damage and death after acute paracetamol ingestion is the extent of delay beyond 8 hours until treatment with NAC commences. 8/27/2018 9
  • 10. Clinical Features- Early after acute overdose, there are usually no symptoms other than nausea and vomiting. Clinical evidence of end-organ toxicity often does not manifest until 24-48 hours after an acute ingestion After 24-48 hours, ALT and AST begin to rise(hepatic necrosis) Acute renal failure occurs occasionally. Liver damage is maximal 3-4 days after ingestion Despite a lack of significant symptoms, patients should be referred to hospital. 8/27/2018 10
  • 11. Time after ingestion TEST 1-8 hr 8-24 hr > 24 hr Paracetamol level At 4 hours or as soon thereafter as possible On admission On admission GOT/GPT On admission AND at end of NAC infusion On admission PT/ INR On admission Urea/ Creat On admission Glucose On admission ABG On admission Recommended investigations 8/27/2018 11
  • 12. • Transaminase X Paracetamol product <10,000 – At the time treatment starts and again at 12 hours – Lifethreatening toxicity is unlikely 8/27/2018 12
  • 16. Three-stage N-acetylcysteine infusion Initial infusion 150 mg/kg of NAC diluted in 200 mL of 5% glucose and infused over 15 to 60 minutes Second infusion Followed by a continuous infusion of 50 mg/kg of NAC in 500 mL of 5% glucose over the next 4 hours Third infusion followed by a continuous infusion of 100 mg/kg of NAC in 1000 mL of 5% glucose over the next 16 hours 8/27/2018 16
  • 17. Anaphylactoid reactions ( 10-50% of patients during first two NAC infusion) Rash, wheeze or mild hypotension Severe life-threatening reactions are very rare, but may occur in predisposed individuals, such as patients with asthma. Management Supportive, with temporary halting or slowing of the infusion, and administration of antihistamines. The occurrence of an anaphylactoid reaction does not preclude the use of NAC on another occasion if indicated.8/27/2018 17
  • 18. Oral NAC ( available as mucolytic agent ) 140 mg/kg stat followed by 70mg/kg 4 hourly for 17 doses with anti-emetic to prevent vomiting. 8/27/2018 18
  • 19. The 2006 Cochrane review of several case series concluded there was no clear difference in efficacy (in terms of hepatoxicity and mortality rates) between intravenous and oral routes. Oral NAC has been used for 30 years in the USA with similar efficacy and safety Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis (Green JL et. al. West J Emerg Med. 2013 May; 14(3): 218–226) 5164 patients in 16 articles The overall rate of hepatotoxicity for the oral and IV routes were 12.6% and 13.2%, respectively. 8/27/2018 19
  • 20. Don’t underestimate paracetamol poisoning Stated timing and dose are often unreliable and this needs to be taken into consideration. NAC is a safe and effective antidote. Time to NAC is crucial. May be asymptomatic in first 24 hours 8/27/2018 20